Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, ...
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's disappointing fourth-quarter 2024 revenue results. Vaishali Prayag Your Healthcare ...
U.S. health benefits company Elevance Health, Inc. ELV shares have declined 29.6% ... The stock witnessed 10 downward estimate revisions for 2024 earnings in the past 60 days against no ...
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...